Doximity, Inc.
Financial highlights
| Metric | FY March 31, 2026 | FY March 31, 2025 | FY March 31, 2024 | FY March 31, 2023 | FY March 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $644.9M | $570.4M | $475.4M | $419.1M | $343.5M |
| Gross profit | $574.5M | $514.5M | $424.8M | $365.6M | $303.8M |
| Operating income | $214.9M | $227.8M | $163.9M | $125.1M | $113.5M |
| Operating expenses | $359.6M | $286.7M | $260.9M | $240.5M | $190.2M |
| Cost of revenue | $70.3M | $55.9M | $50.7M | $53.5M | $39.8M |
| Cash from operations | $326.5M | $273.3M | $184.1M | $179.6M | $126.6M |
| Capital expenditure | $0 | $0 | $147,000 | $1.7M | $1.9M |
| Free cash flow | $326.5M | $273.3M | $183.9M | $177.9M | $124.7M |
| Share repurchases | $431.7M | $120.3M | $280.7M | $85.3M | $2.7M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $1.1B | $1.3B | $1.1B | $1.1B | $991.4M |
| Total liabilities | $172.8M | $181.7M | $178.0M | $170.8M | $112.8M |
Shares outstanding 184.7M · Free float 3.8%
Annual filing data through FY ended March 31, 2026; float as of July 4, 2026.